4 patents
Utility
Red Cell Diluent with Chelating Agent and Methods for Making and Using the Same
23 Nov 23
The present disclosure relates to a RBC solution comprising ethylenediaminetetraacetic acid (EDTA) and methods for making and using the same.
Mortimer ALONZA, Bryan MARSHALL, Elizabeth COPE, Margot BORGEL, Teresa WELCH
Filed: 4 Aug 23
Utility
Red cell diluent with EDTA and methods for making and using the same
12 Sep 23
The present disclosure relates to a red blood cell (RBC) solution comprising ethylenediaminetetraacetic acid (EDTA) and methods for making and using the same.
Mortimer Alzona, Bryan Marshall, Elizabeth Cope, Margot Borgel, Teresa Welch
Filed: 3 Apr 18
Utility
Red Cell Diluent with Edta and Methods for Making and Using the Same
17 Jun 20
The present disclosure relates to a red blood cell (RBC) solution comprising ethylenediaminetetraacetic acid (EDTA) and methods for making and using the same.
Mortimer ALZONA, Bryan MARSHALL, Elizabeth COPE, Margot ZACCARDI, Teresa WELCH
Filed: 2 Apr 18
Utility
Polypeptide substrate for the detection of von Williebrand factor cleaving protease ADAMTS13
20 Jan 20
In a first aspect, there is provided an isolated polypeptide substrate for a disintegrin-like and metallopeptidase with thrombospondin type-1 motif, 13 (ADAMTS13) that is from 45 to 70 amino acids in length and has an amino acid sequence that is substantially similar to part of the von Willebrand factor A2 domain sequence set forth in SEQ ID NO: 2, with one or more of the following modifications: (i) the amino acid corresponding to position 1599 of SEQ ID NO: 2 is mutated from Q to K; (ii) the amino acid corresponding to position 1610 of SEQ ID NO: 2 is mutated from N to C; and (iii) the amino acids corresponding to Q1624 to R1641 of SEQ ID NO: 2 are deleted.
Gian Paolo Visentin, Suzette C. Chance, Elizabeth Wuitschick
Filed: 19 Dec 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first